2017 San Antonio Breast Cancer Symposium (SABCS)

05 December 2017 - 09 December 2017

Statins linked to better breast cancer-specific survival

Jackey Suen, 20180103041543

Women with breast cancer who took statins regularly had significantly better breast cancer-specific survival than those who did not take any statins, a Swedish study has shown. [SABCS 2017, poster P2-13-03]

Acupuncture effectively reduces joint pain among breast cancer patients on aromatase inhibitors

Dr. Joseph Delano Fule Robles, 20171215092659

A recent study presented at the 2017 San Antonio Breast Cancer Symposium (SABCS) showed that acupuncture is effective in reducing aromatase inhibitor–induced joint symptoms among breast cancer patients.

Adding trastuzumab to adjuvant chemo does not improve outcomes in HER2-low breast cancer

Christina Lau, 20171215041209

Adding trastuzumab to standard adjuvant chemotherapy does not improve survival or reduce recurrence in patients with early-stage breast cancer expressing low levels of HER2, according to results of a National Surgical Adjuvant Breast and Bowel Project study reported at the 2017 San Antonio Breast Cancer Symposium (SABCS).

Pembrolizumab overcomes trastuzumab resistance in advanced breast cancer

Dr. Joseph Delano Fule Robles, 20171213073227

The phase IB/II PANACEA study recently showed that the addition of pembrolizumab to trastuzumab in patients with trastuzumab-resistant advanced HER2-positive breast cancer resulted in disease control with a tolerable safety profile.

Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!

Ribociclib offers survival benefit in premenopausal women with HR+/HER2- advanced breast cancer

12 Jun 2020

Drawing from experience as a key investigator in landmark clinical trials (including PALOMA, MONALEESA and MONARCH), and his clinical experience with CDK4/6 inhibitors, Dr Rafael Villanueva Vázquez shares his insights into the current evidence of using CDK4/6 inhibitors to treat HR+/HER2- ABC.

Fertility preservation vital in female cancer survivors

Roshini Claire Anthony, 04 Aug 2020

Female cancer survivors who undergo fertility preservation before cancer treatment often use their stored gametes/embryos. This highlights the effectiveness of pre-cancer fertility preservation, according to a study presented at ESHRE 2020.